ScanTech AI Systems Inc. Material Event - What You Need to Know

ScanTech AI Systems Inc. faces a critical turning point: its imminent delisting from the Nasdaq stock exchange. This is vital information for anyone invested in or considering ScanTech. We've cut through the jargon to explain what this means for the company and its investors.

---

1. Event Description (The Core Event)

ScanTech AI Systems Inc. faces a significant challenge: Nasdaq will delist its stock. This is a final decision, not a warning. Trading of ScanTech's stock on Nasdaq will officially cease at the open of business on February 10, 2026.

2. Event Date/Timeline

The situation developed rapidly:

• February 4, 2026: ScanTech first received a warning letter from Nasdaq, citing non-compliance with listing rules.
• February 6, 2026: The company received the official delisting letter, confirming Nasdaq's decision.
• February 10, 2026: Nasdaq will suspend trading in ScanTech's stock. This date is fast approaching.

3. Reasons for Delisting

Nasdaq maintains strict rules to ensure its listed companies are financially sound and transparent. ScanTech failed to meet several of these fundamental requirements:

• Insufficient Publicly Held Shares Value: ScanTech's publicly traded shares (those available to regular investors) fell below Nasdaq's required $15 million minimum market value for 30 consecutive business days. This indicates a lack of investor interest or a significant decline in share price.
• Failure to File Timely Reports: Critically, ScanTech violated Nasdaq's "Periodic Filing Rule." The company failed to submit its required financial reports and other important documents to the SEC (Securities and Exchange Commission) on time. Specifically, ScanTech has not filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, nor its Quarterly Report on Form 10-Q for the period ended September 30, 2025. This represents a major red flag for transparency and financial health.
• Overall Low Market Value: The company also failed to meet Nasdaq's minimum $50 million Market Value of Listed Securities (MVLS) requirement. This means the total value of all its shares trading on Nasdaq fell below this threshold.

These multiple violations suggest significant underlying financial and operational challenges within ScanTech.

4. Impact Assessment (Broader Impact & Affected Parties)

Delisting from a major exchange like Nasdaq is a severe blow, signaling deep-seated issues and creating substantial hurdles for the company. Its consequences include:

• Loss of Credibility: ScanTech's reputation will suffer significantly, making it harder to attract new investors, secure partnerships, or retain customers who rely on a stable, transparent business.
• Reduced Visibility and Liquidity: Nasdaq offers high visibility and easy trading. Moving to a less prominent market means fewer investors will discover ScanTech, and buying or selling its stock will become much harder. This often leads to wider price swings and lower valuations.
• Difficulty Raising Capital: Companies often use their stock to raise funds. Delisting makes this process significantly more difficult and expensive, hindering ScanTech's ability to finance operations, research, and growth initiatives.
• Uncertain Financial Health: The failure to file financial reports means investors lack current, audited information about ScanTech's financial performance, cash flow, and overall stability. This makes informed investment decisions nearly impossible.

Essentially, this event fundamentally alters ScanTech's future prospects, making its path forward considerably more challenging.

Who is affected?

The ripples of this news extend to many stakeholders:

• Investors/Traders (If you own ScanTech stock): This is the most direct impact. Your shares will no longer trade on Nasdaq. While ScanTech plans to apply to trade on the OTCQB Venture Market, approval is not guaranteed. Even if approved, trading on OTCQB typically means significantly lower volume, making it much harder to buy or sell shares when you want to, and often leading to a substantial drop in the stock's price.
• ScanTech Employees: The company's financial struggles and difficulty raising capital create significant uncertainty about job security, future growth opportunities, and the company's long-term viability.
• ScanTech Customers: They may become concerned about the company's ability to continue developing products, provide ongoing support, or even remain in business, especially given the lack of transparent financial reporting.
• Competitors and Partners: Competitors might seize the opportunity to gain market share, while current or potential partners may reconsider their relationships with ScanTech due to increased risk and instability.

5. Financial Impact

The Nasdaq delisting will likely have severe and immediate financial repercussions for ScanTech AI Systems Inc.:

• Significant Stock Price Depreciation and Reduced Market Capitalization: Moving to a less liquid, over-the-counter market typically results in a substantial decline in the company's stock price and overall market valuation.
• Impaired Access to Capital: The company's ability to raise capital through equity offerings will significantly diminish. Future capital raises will likely come at a higher cost and with more restrictive terms, potentially constraining funding for operations, research, and growth initiatives.
• Increased Operating Costs (Administrative & Legal): The delisting process itself, including potential appeals and the application to alternative trading platforms, will incur legal, administrative, and advisory fees.
• Potential Impact on Debt Covenants: Delisting could trigger provisions in existing debt agreements, potentially leading to demands for accelerated repayment or renegotiation of terms. This could further strain the company's financial position.
• Reduced Liquidity for Shareholders: Diminished trading volume on an alternative market will make it considerably more difficult for existing shareholders to sell their shares, potentially locking in losses.
• Uncertainty Due to Unfiled Financials: The absence of timely filed financial reports (10-K for FY2025 and 10-Q for Q3 2025) prevents investors and creditors from accurately assessing the company's current financial health, cash flow, and operational performance, exacerbating financial uncertainty.

6. What Happens Next? (Immediate and Future Implications)

Here's what to expect in the coming weeks and months:

• Immediate Suspension: Trading on Nasdaq will cease on February 10, 2026.
• Appeal Option: ScanTech has 15 days from February 6 to submit a written request to appeal Nasdaq's delisting decision to the Nasdaq Listing and Hearing Review Council. The company is currently exploring this option, though successful appeals for multiple violations are uncommon.
• Alternative Trading Market: ScanTech intends to apply to have its shares quoted on the OTCQB Venture Market. This is a less regulated, over-the-counter market, and there is no assurance that their application will be approved or that a liquid market will develop.
• Addressing Underlying Issues: Beyond the delisting process, the company faces the critical task of addressing the root causes of its non-compliance. This includes filing its delinquent financial reports and improving its financial health to regain investor confidence and operational stability. Without a clear strategy to resolve these issues, the company's long-term future remains highly uncertain.

7. Key Takeaways for Investors

For those holding or considering ScanTech stock, here are the key takeaways:

• Delisting is Imminent: The stock will stop trading on Nasdaq on February 10. This is a definitive event.
• Severe Liquidity and Price Risk: If the stock moves to an over-the-counter market, expect significantly reduced trading volume. This will make it very difficult to buy or sell shares and typically leads to wider bid-ask spreads and a substantial negative impact on the stock price.
• Lack of Financial Transparency: With delinquent financial filings, investors have no current, reliable information to assess the company's financial health. This makes any investment decision highly speculative and risky.
• Appeal is a Long Shot: While an appeal is possible, successfully overturning a delisting decision based on multiple, fundamental rule violations is rare.
• Re-evaluate Your Position: This news fundamentally changes the investment landscape for ScanTech. You must carefully consider the company's viability, its ability to address its financial and operational challenges, and the implications of trading on a less regulated market.
• Stay Informed (if possible): Watch for any announcements regarding their appeal, their application to the OTCQB, and critically, any updates on their delinquent financial filings. However, expect information to be scarcer.